Rationale for a study adding tamoxifen to HRT

European Journal of Cancer

Volumn 38, Issue SUPPL. 6, 2002, Pages

  Rotmensz, N ^a   Decensi, A ^a   Maisonneuve, P ^a   Costa, A ^a   Sacchini, V ^a   Travaglini, R ^b   D'Aiuto, G ^c   Lovison, F ^d   Gucciardo, G ^e   Muraca, M G ^f   Pizzichetta, M A ^g   Conforti, S ^h   Robertson, C ^a   Boyle, P ^a   Veronesi, U ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b Clinical Research Unit   (Italy)

^c Clinical Unit   (Italy)

^d Clinical Unit   (Italy)

^e S Camillo   (Italy)

^f CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^g CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^h M Santo Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; ITALY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; PHLEBITIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

EID: 0036753601     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0959-8049(02)00272-1     Document Type: Article

References (5)

1. Jaiyesimi I.A., Buzdar A.U., Decker D.A., Hortobagyi G.N. Use of tamoxifen for breast cancer. twenty-eight years later J. Clin. Oncol. 13:1995;513-529.
2. Powles T., Eeles R., Ashley S.et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial. Lancet. 352:1998;98-101.
3. Veronesi U., Maisonneuve P., Costa A.et al. Prevention of breast cancer with tamoxifen. preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Preventional Study Lancet. 352:1998;93-97.
4. Fisher B., Costantino J.P., Wickerham D.L.et al. Tamoxifen for prevention of breast cancer. report of the National Surgical Adjuvent Breast and Bowel Project P-1 Study J. Natl. Cancer Inst. 90:1998;1371-1388.
5. Decensi A., Gandini S., Guerrieri-Gonzaga A.et al. Effect of blood tamoxifen concentrations on surrogate biomarkers in a trial of dose reduction. J. Clin. Oncol. 17:1999;2633-2638.